Lucid News· Jack Gorsline·AI score60
FDA holds public hearing on future therapeutic use of psychedelic drugs
FDA Holds Historic Public Hearing on Psychedelic Therapies
AI summary
The FDAFDAThe Food and Drug Administration, the United States regulator of medicines, medical devices and food.Open the glossary held a public hearing at its White Oak campus in Silver Spring, Maryland.
Key facts
- Kind of item
- Guidance and consultations
- Compounds
- Psilocybin, MDMA, Ibogaine
- Regulator
- FDA (United States)
- Jurisdiction
- United States
- Source
- Lucid News (lucid.news)
- Published
- Original
- Read it at lucid.news
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Lucid News · lucid.news
Connected to
- Kind of item
- Guidance and consultations
- Compounds
- PsilocybinMDMAIbogaine
- Regulator
- FDA (United States)
- Jurisdiction
- United States